| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fetoscopy | 85 | 2025 | 449 | 15.200 |
Why?
|
| Pregnancy | 398 | 2025 | 7180 | 10.270 |
Why?
|
| Fetal Diseases | 45 | 2025 | 455 | 8.570 |
Why?
|
| Fetofetal Transfusion | 43 | 2025 | 194 | 8.160 |
Why?
|
| Meningomyelocele | 31 | 2025 | 251 | 7.770 |
Why?
|
| Placenta Accreta | 33 | 2025 | 157 | 7.740 |
Why?
|
| Pre-Eclampsia | 53 | 2023 | 221 | 6.450 |
Why?
|
| Cesarean Section | 46 | 2025 | 387 | 6.120 |
Why?
|
| Ultrasonography, Prenatal | 85 | 2025 | 969 | 5.560 |
Why?
|
| Hysterectomy | 27 | 2025 | 191 | 5.180 |
Why?
|
| Hysterotomy | 21 | 2025 | 126 | 5.160 |
Why?
|
| Delivery, Obstetric | 26 | 2023 | 250 | 4.430 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 27 | 2025 | 401 | 4.330 |
Why?
|
| Spinal Dysraphism | 14 | 2023 | 270 | 4.270 |
Why?
|
| Prenatal Care | 23 | 2023 | 348 | 4.210 |
Why?
|
| Gestational Age | 72 | 2025 | 1159 | 4.070 |
Why?
|
| Cerebrovascular Circulation | 26 | 2021 | 432 | 4.060 |
Why?
|
| Female | 413 | 2025 | 66301 | 3.970 |
Why?
|
| Premature Birth | 21 | 2023 | 385 | 3.960 |
Why?
|
| Neural Tube Defects | 17 | 2024 | 355 | 3.900 |
Why?
|
| Pregnancy Outcome | 53 | 2025 | 588 | 3.720 |
Why?
|
| Pregnancy, Twin | 37 | 2025 | 180 | 3.380 |
Why?
|
| Infant, Newborn | 114 | 2025 | 8189 | 3.220 |
Why?
|
| Airway Obstruction | 6 | 2023 | 165 | 3.050 |
Why?
|
| Humans | 424 | 2025 | 124227 | 2.850 |
Why?
|
| Prenatal Diagnosis | 31 | 2025 | 597 | 2.840 |
Why?
|
| Laser Therapy | 15 | 2023 | 249 | 2.730 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 21 | 2021 | 107 | 2.510 |
Why?
|
| Pregnancy Complications | 26 | 2022 | 511 | 2.500 |
Why?
|
| Adult | 182 | 2025 | 29367 | 2.490 |
Why?
|
| Fetus | 29 | 2024 | 586 | 2.460 |
Why?
|
| Retrospective Studies | 134 | 2025 | 16276 | 2.410 |
Why?
|
| Placenta | 24 | 2023 | 506 | 2.300 |
Why?
|
| Middle Cerebral Artery | 13 | 2022 | 107 | 2.270 |
Why?
|
| Laser Coagulation | 14 | 2024 | 129 | 2.250 |
Why?
|
| Umbilical Arteries | 14 | 2021 | 95 | 2.180 |
Why?
|
| Heart Rate, Fetal | 13 | 2021 | 61 | 2.150 |
Why?
|
| Blood Loss, Surgical | 13 | 2025 | 154 | 2.080 |
Why?
|
| Fetal Therapies | 12 | 2025 | 80 | 2.030 |
Why?
|
| Placenta Previa | 14 | 2024 | 65 | 2.030 |
Why?
|
| Magnesium Sulfate | 19 | 2021 | 49 | 1.900 |
Why?
|
| Amniotic Band Syndrome | 4 | 2020 | 24 | 1.800 |
Why?
|
| Obstetric Labor Complications | 12 | 2019 | 92 | 1.780 |
Why?
|
| Cardiotocography | 7 | 2022 | 19 | 1.780 |
Why?
|
| Postpartum Hemorrhage | 11 | 2025 | 96 | 1.770 |
Why?
|
| Eclampsia | 11 | 2021 | 29 | 1.660 |
Why?
|
| Homeostasis | 7 | 2021 | 685 | 1.620 |
Why?
|
| Urethral Obstruction | 8 | 2023 | 56 | 1.610 |
Why?
|
| Blood Pressure | 28 | 2019 | 1351 | 1.610 |
Why?
|
| Hypertension, Pregnancy-Induced | 5 | 2024 | 74 | 1.590 |
Why?
|
| Blood Flow Velocity | 24 | 2015 | 434 | 1.560 |
Why?
|
| Placenta Diseases | 7 | 2022 | 59 | 1.550 |
Why?
|
| Pregnancy Trimester, Second | 17 | 2021 | 165 | 1.550 |
Why?
|
| Neurosurgical Procedures | 7 | 2021 | 303 | 1.510 |
Why?
|
| Balloon Occlusion | 7 | 2025 | 47 | 1.480 |
Why?
|
| Pregnancy Complications, Cardiovascular | 10 | 2015 | 104 | 1.470 |
Why?
|
| Fetal Membranes, Premature Rupture | 8 | 2022 | 61 | 1.470 |
Why?
|
| Ultrasonography, Doppler | 12 | 2020 | 194 | 1.460 |
Why?
|
| Amniotic Fluid | 11 | 2025 | 150 | 1.400 |
Why?
|
| Trachea | 10 | 2024 | 203 | 1.390 |
Why?
|
| Oligohydramnios | 6 | 2025 | 46 | 1.370 |
Why?
|
| Brain | 15 | 2024 | 2983 | 1.360 |
Why?
|
| Postoperative Complications | 15 | 2021 | 3058 | 1.340 |
Why?
|
| Treatment Outcome | 44 | 2025 | 12272 | 1.330 |
Why?
|
| Electrocardiography | 7 | 2022 | 968 | 1.320 |
Why?
|
| Carbon Dioxide | 11 | 2023 | 274 | 1.300 |
Why?
|
| Spina Bifida Cystica | 7 | 2024 | 35 | 1.290 |
Why?
|
| Pleural Effusion | 3 | 2024 | 102 | 1.290 |
Why?
|
| Postpartum Period | 8 | 2017 | 215 | 1.240 |
Why?
|
| Laparotomy | 4 | 2024 | 135 | 1.230 |
Why?
|
| Diabetes, Gestational | 8 | 2022 | 112 | 1.220 |
Why?
|
| Magnetic Resonance Imaging | 27 | 2025 | 3552 | 1.220 |
Why?
|
| Young Adult | 36 | 2021 | 8999 | 1.210 |
Why?
|
| Dystocia | 5 | 2015 | 23 | 1.210 |
Why?
|
| Gastroschisis | 4 | 2021 | 54 | 1.160 |
Why?
|
| Cerebral Arteries | 7 | 2015 | 80 | 1.160 |
Why?
|
| Vascular Resistance | 13 | 2015 | 186 | 1.160 |
Why?
|
| Cohort Studies | 37 | 2024 | 4779 | 1.150 |
Why?
|
| Patient Care Team | 6 | 2019 | 542 | 1.150 |
Why?
|
| Labetalol | 3 | 2020 | 12 | 1.150 |
Why?
|
| Fetal Growth Retardation | 11 | 2025 | 239 | 1.140 |
Why?
|
| Lymphatic Abnormalities | 2 | 2019 | 35 | 1.090 |
Why?
|
| Hemodynamics | 15 | 2021 | 848 | 1.070 |
Why?
|
| Puerperal Disorders | 5 | 2016 | 45 | 1.070 |
Why?
|
| Obstetric Labor, Premature | 5 | 2023 | 85 | 1.050 |
Why?
|
| Birth Injuries | 3 | 2015 | 22 | 1.040 |
Why?
|
| Perinatal Care | 6 | 2024 | 67 | 1.030 |
Why?
|
| Walking | 3 | 2024 | 159 | 1.030 |
Why?
|
| Labor, Obstetric | 13 | 2022 | 94 | 1.020 |
Why?
|
| Evidence-Based Medicine | 7 | 2024 | 633 | 1.020 |
Why?
|
| Lung | 18 | 2025 | 1486 | 1.020 |
Why?
|
| Antihypertensive Agents | 6 | 2024 | 411 | 1.020 |
Why?
|
| Amnion | 6 | 2020 | 38 | 1.000 |
Why?
|
| Regional Blood Flow | 6 | 2013 | 205 | 1.000 |
Why?
|
| Teratoma | 3 | 2024 | 121 | 1.000 |
Why?
|
| Placenta, Retained | 3 | 2017 | 12 | 0.990 |
Why?
|
| Obstetrics | 10 | 2018 | 238 | 0.990 |
Why?
|
| Twins, Monozygotic | 14 | 2025 | 117 | 0.990 |
Why?
|
| Pregnancy Complications, Infectious | 7 | 2024 | 450 | 0.980 |
Why?
|
| Polyhydramnios | 7 | 2025 | 56 | 0.970 |
Why?
|
| Adrenomedullin | 8 | 2022 | 74 | 0.960 |
Why?
|
| Uterine Artery | 5 | 2022 | 29 | 0.960 |
Why?
|
| Embolism, Amniotic Fluid | 4 | 2020 | 31 | 0.950 |
Why?
|
| Urologic Diseases | 3 | 2021 | 44 | 0.950 |
Why?
|
| Surgical Wound Dehiscence | 3 | 2020 | 50 | 0.940 |
Why?
|
| Fetal Death | 12 | 2023 | 112 | 0.940 |
Why?
|
| Laryngoscopy | 2 | 2019 | 151 | 0.930 |
Why?
|
| Nifedipine | 3 | 2020 | 21 | 0.910 |
Why?
|
| Urinary Bladder Neck Obstruction | 4 | 2018 | 29 | 0.910 |
Why?
|
| Infant | 29 | 2025 | 12464 | 0.910 |
Why?
|
| Uterine Hemorrhage | 5 | 2020 | 43 | 0.890 |
Why?
|
| Abruptio Placentae | 2 | 2022 | 17 | 0.890 |
Why?
|
| Blood Transfusion | 6 | 2025 | 309 | 0.890 |
Why?
|
| Prospective Studies | 30 | 2023 | 6121 | 0.890 |
Why?
|
| Telemedicine | 3 | 2022 | 428 | 0.880 |
Why?
|
| Uterine Rupture | 3 | 2020 | 18 | 0.870 |
Why?
|
| Hydrocephalus | 7 | 2024 | 242 | 0.860 |
Why?
|
| Adrenal Cortex Hormones | 3 | 2023 | 317 | 0.860 |
Why?
|
| Fetal Weight | 5 | 2023 | 61 | 0.850 |
Why?
|
| Parturition | 3 | 2019 | 62 | 0.850 |
Why?
|
| Case-Control Studies | 22 | 2025 | 3268 | 0.840 |
Why?
|
| Hypoplastic Left Heart Syndrome | 4 | 2019 | 252 | 0.840 |
Why?
|
| Infertility, Female | 2 | 2021 | 144 | 0.840 |
Why?
|
| Myometrium | 3 | 2020 | 47 | 0.830 |
Why?
|
| Insufflation | 3 | 2020 | 20 | 0.830 |
Why?
|
| Patient Simulation | 1 | 2023 | 39 | 0.820 |
Why?
|
| Cicatrix | 2 | 2022 | 122 | 0.810 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 29 | 0.800 |
Why?
|
| Hypocalcemia | 2 | 2019 | 36 | 0.790 |
Why?
|
| Hypertension | 10 | 2022 | 1318 | 0.790 |
Why?
|
| Critical Illness | 5 | 2015 | 603 | 0.780 |
Why?
|
| Simulation Training | 3 | 2022 | 139 | 0.780 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2021 | 43 | 0.770 |
Why?
|
| Uterus | 7 | 2022 | 569 | 0.770 |
Why?
|
| Hemangioma | 2 | 2022 | 94 | 0.770 |
Why?
|
| Urogenital Abnormalities | 2 | 2021 | 154 | 0.760 |
Why?
|
| Fetal Heart | 8 | 2024 | 115 | 0.760 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2021 | 22 | 0.750 |
Why?
|
| Laparoscopy | 3 | 2021 | 494 | 0.750 |
Why?
|
| Maternal Mortality | 4 | 2018 | 80 | 0.730 |
Why?
|
| Erythrocyte Transfusion | 6 | 2020 | 129 | 0.720 |
Why?
|
| Wound Closure Techniques | 1 | 2020 | 23 | 0.700 |
Why?
|
| Pregnancy Trimester, First | 6 | 2022 | 114 | 0.690 |
Why?
|
| Omentum | 9 | 2022 | 47 | 0.690 |
Why?
|
| Anterior Cerebral Artery | 2 | 2013 | 8 | 0.680 |
Why?
|
| Polytetrafluoroethylene | 1 | 2020 | 84 | 0.670 |
Why?
|
| Risk Factors | 34 | 2024 | 10239 | 0.670 |
Why?
|
| Polycythemia | 5 | 2024 | 43 | 0.670 |
Why?
|
| Vasa Previa | 2 | 2019 | 9 | 0.660 |
Why?
|
| Shoulder | 2 | 2012 | 27 | 0.660 |
Why?
|
| Decision Making | 3 | 2020 | 654 | 0.660 |
Why?
|
| Anesthesia, Obstetrical | 2 | 2024 | 33 | 0.650 |
Why?
|
| Disease Management | 5 | 2018 | 518 | 0.640 |
Why?
|
| Thulium | 1 | 2019 | 6 | 0.640 |
Why?
|
| Lymphatic Vessels | 1 | 2019 | 37 | 0.630 |
Why?
|
| Intraoperative Care | 1 | 2019 | 106 | 0.620 |
Why?
|
| Perinatal Death | 3 | 2023 | 26 | 0.620 |
Why?
|
| Ultrasonography | 14 | 2022 | 931 | 0.620 |
Why?
|
| Hospitals, High-Volume | 1 | 2018 | 35 | 0.610 |
Why?
|
| Clinical Competence | 4 | 2018 | 994 | 0.610 |
Why?
|
| Ultrasonography, Interventional | 3 | 2019 | 192 | 0.610 |
Why?
|
| Women's Health Services | 2 | 2019 | 14 | 0.600 |
Why?
|
| Neck | 1 | 2019 | 136 | 0.580 |
Why?
|
| Blood Coagulation Disorders | 1 | 2019 | 103 | 0.580 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2019 | 118 | 0.580 |
Why?
|
| Practice Guidelines as Topic | 10 | 2024 | 1264 | 0.570 |
Why?
|
| Fetal Development | 1 | 2019 | 132 | 0.560 |
Why?
|
| Retinal Artery | 7 | 1999 | 16 | 0.560 |
Why?
|
| Multipotent Stem Cells | 1 | 2017 | 27 | 0.560 |
Why?
|
| Cystoscopy | 2 | 2016 | 44 | 0.560 |
Why?
|
| Lung Volume Measurements | 8 | 2025 | 75 | 0.560 |
Why?
|
| Hydrops Fetalis | 7 | 2022 | 75 | 0.560 |
Why?
|
| Pulsatile Flow | 7 | 2021 | 127 | 0.550 |
Why?
|
| Predictive Value of Tests | 17 | 2021 | 2142 | 0.550 |
Why?
|
| Infant Mortality | 7 | 2022 | 174 | 0.550 |
Why?
|
| Post-Dural Puncture Headache | 1 | 2016 | 3 | 0.550 |
Why?
|
| Sensitivity and Specificity | 16 | 2021 | 2041 | 0.540 |
Why?
|
| Lasers | 8 | 2024 | 114 | 0.540 |
Why?
|
| Hemostasis, Surgical | 1 | 2016 | 37 | 0.540 |
Why?
|
| Birth Weight | 8 | 2022 | 346 | 0.530 |
Why?
|
| Betacoronavirus | 1 | 2020 | 286 | 0.530 |
Why?
|
| Healthcare Disparities | 3 | 2022 | 428 | 0.530 |
Why?
|
| Cerebrum | 1 | 2016 | 33 | 0.530 |
Why?
|
| Biomedical Research | 3 | 2019 | 516 | 0.510 |
Why?
|
| Neural Stem Cells | 1 | 2017 | 120 | 0.510 |
Why?
|
| Interdisciplinary Communication | 1 | 2017 | 130 | 0.510 |
Why?
|
| Arm Injuries | 1 | 2015 | 13 | 0.510 |
Why?
|
| Ultrasonography, Doppler, Color | 4 | 2018 | 58 | 0.510 |
Why?
|
| Clinical Protocols | 3 | 2014 | 240 | 0.510 |
Why?
|
| Intubation, Intratracheal | 1 | 2019 | 291 | 0.500 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 4 | 2022 | 79 | 0.490 |
Why?
|
| Vagina | 1 | 2017 | 193 | 0.490 |
Why?
|
| Labor Stage, Second | 4 | 2022 | 16 | 0.480 |
Why?
|
| Breath Holding | 1 | 2015 | 5 | 0.480 |
Why?
|
| Uterine Balloon Tamponade | 2 | 2013 | 6 | 0.480 |
Why?
|
| Severity of Illness Index | 13 | 2021 | 2883 | 0.480 |
Why?
|
| Education, Medical, Continuing | 2 | 2018 | 140 | 0.480 |
Why?
|
| Organ Sparing Treatments | 1 | 2015 | 36 | 0.470 |
Why?
|
| Intracranial Pressure | 3 | 2021 | 182 | 0.470 |
Why?
|
| Adolescent | 24 | 2022 | 19260 | 0.470 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 356 | 0.470 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 370 | 0.470 |
Why?
|
| Heart Defects, Congenital | 5 | 2024 | 1813 | 0.470 |
Why?
|
| Anticonvulsants | 4 | 2006 | 375 | 0.470 |
Why?
|
| Prognosis | 18 | 2021 | 4608 | 0.460 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 154 | 0.460 |
Why?
|
| Evidence-Based Practice | 1 | 2015 | 112 | 0.460 |
Why?
|
| Echocardiography, Four-Dimensional | 1 | 2014 | 18 | 0.460 |
Why?
|
| Peptide Hormones | 4 | 2022 | 68 | 0.460 |
Why?
|
| Endoscopy | 3 | 2019 | 280 | 0.450 |
Why?
|
| Lung Diseases | 6 | 2022 | 384 | 0.450 |
Why?
|
| Perinatal Mortality | 6 | 2020 | 43 | 0.450 |
Why?
|
| Stillbirth | 4 | 2022 | 80 | 0.450 |
Why?
|
| Hydrothorax | 1 | 2014 | 11 | 0.450 |
Why?
|
| Analgesia, Obstetrical | 1 | 2013 | 8 | 0.440 |
Why?
|
| Anesthesia, Spinal | 1 | 2013 | 8 | 0.440 |
Why?
|
| Umbilical Cord | 5 | 2022 | 56 | 0.440 |
Why?
|
| Cardiac Tamponade | 1 | 2014 | 37 | 0.440 |
Why?
|
| Ophthalmic Artery | 5 | 2013 | 24 | 0.440 |
Why?
|
| Posterior Cerebral Artery | 1 | 2013 | 6 | 0.430 |
Why?
|
| Analgesia, Epidural | 1 | 2013 | 28 | 0.430 |
Why?
|
| Implants, Experimental | 1 | 2013 | 7 | 0.430 |
Why?
|
| Fetal Macrosomia | 3 | 2022 | 20 | 0.430 |
Why?
|
| Male | 38 | 2025 | 61018 | 0.420 |
Why?
|
| Abortion, Spontaneous | 3 | 2022 | 79 | 0.420 |
Why?
|
| Muscle, Smooth, Vascular | 6 | 2021 | 238 | 0.420 |
Why?
|
| Emergency Medicine | 1 | 2015 | 155 | 0.420 |
Why?
|
| Vocal Cords | 1 | 2013 | 65 | 0.420 |
Why?
|
| Indomethacin | 4 | 2021 | 84 | 0.420 |
Why?
|
| Pregnancy Trimester, Third | 6 | 2017 | 117 | 0.420 |
Why?
|
| Calcitonin Gene-Related Peptide | 4 | 2021 | 87 | 0.420 |
Why?
|
| Vasodilation | 6 | 2016 | 190 | 0.410 |
Why?
|
| Vasoconstriction | 5 | 2015 | 101 | 0.410 |
Why?
|
| Blood Transfusion, Intrauterine | 7 | 2024 | 37 | 0.410 |
Why?
|
| Diseases in Twins | 4 | 2021 | 94 | 0.400 |
Why?
|
| Pandemics | 1 | 2020 | 1096 | 0.400 |
Why?
|
| Intensive Care Units | 2 | 2015 | 490 | 0.400 |
Why?
|
| Zika Virus Infection | 4 | 2019 | 170 | 0.400 |
Why?
|
| Pregnancy, Triplet | 2 | 2022 | 10 | 0.400 |
Why?
|
| Anemia | 3 | 2022 | 339 | 0.390 |
Why?
|
| Overweight | 1 | 2015 | 363 | 0.390 |
Why?
|
| Adipose Tissue | 3 | 2022 | 461 | 0.390 |
Why?
|
| Urinary Bladder | 4 | 2023 | 245 | 0.390 |
Why?
|
| Nimodipine | 3 | 1999 | 7 | 0.390 |
Why?
|
| Echocardiography | 8 | 2021 | 1050 | 0.390 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2022 | 42 | 0.380 |
Why?
|
| Calcium Channel Blockers | 5 | 2003 | 115 | 0.380 |
Why?
|
| United States | 23 | 2021 | 10874 | 0.380 |
Why?
|
| Vasodilator Agents | 4 | 2003 | 204 | 0.380 |
Why?
|
| Pregnancy in Diabetics | 3 | 2022 | 19 | 0.370 |
Why?
|
| Urinary Tract | 3 | 2023 | 60 | 0.370 |
Why?
|
| Extraction, Obstetrical | 3 | 2016 | 9 | 0.370 |
Why?
|
| Child, Preschool | 8 | 2024 | 14000 | 0.360 |
Why?
|
| Liver Diseases | 4 | 2016 | 366 | 0.360 |
Why?
|
| Respiratory System Abnormalities | 2 | 2022 | 42 | 0.350 |
Why?
|
| Blood Volume | 3 | 2008 | 80 | 0.350 |
Why?
|
| Reference Values | 7 | 2017 | 711 | 0.350 |
Why?
|
| Skull | 1 | 2012 | 142 | 0.350 |
Why?
|
| Apgar Score | 3 | 2021 | 47 | 0.340 |
Why?
|
| Nervous System Malformations | 2 | 2023 | 130 | 0.340 |
Why?
|
| Arteries | 6 | 2016 | 221 | 0.340 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2022 | 158 | 0.340 |
Why?
|
| Stents | 4 | 2022 | 877 | 0.340 |
Why?
|
| Cholecystitis | 1 | 2009 | 20 | 0.330 |
Why?
|
| Hypertension, Pulmonary | 3 | 2021 | 436 | 0.330 |
Why?
|
| Estradiol | 6 | 2001 | 535 | 0.330 |
Why?
|
| Drainage | 6 | 2018 | 257 | 0.330 |
Why?
|
| Vasoconstrictor Agents | 6 | 2019 | 136 | 0.320 |
Why?
|
| Motor Activity | 3 | 2021 | 509 | 0.320 |
Why?
|
| Chromosome Disorders | 3 | 2018 | 311 | 0.320 |
Why?
|
| Obstetrical Forceps | 3 | 2016 | 8 | 0.310 |
Why?
|
| Umbilical Veins | 6 | 2021 | 73 | 0.310 |
Why?
|
| Arnold-Chiari Malformation | 2 | 2023 | 50 | 0.310 |
Why?
|
| Chorioamnionitis | 3 | 2022 | 42 | 0.310 |
Why?
|
| Reproducibility of Results | 12 | 2021 | 2861 | 0.300 |
Why?
|
| ROC Curve | 7 | 2022 | 566 | 0.300 |
Why?
|
| alpha-Fetoproteins | 3 | 2021 | 132 | 0.300 |
Why?
|
| Vacuum Extraction, Obstetrical | 1 | 2008 | 3 | 0.300 |
Why?
|
| Kidney | 3 | 2021 | 1357 | 0.300 |
Why?
|
| Health Status Indicators | 2 | 2017 | 122 | 0.300 |
Why?
|
| Labor, Induced | 4 | 2021 | 34 | 0.300 |
Why?
|
| Appendicitis | 1 | 2009 | 126 | 0.290 |
Why?
|
| Quality of Health Care | 5 | 2017 | 388 | 0.290 |
Why?
|
| Neurodevelopmental Disorders | 2 | 2025 | 500 | 0.290 |
Why?
|
| In Vitro Techniques | 14 | 2022 | 970 | 0.290 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2018 | 728 | 0.280 |
Why?
|
| Intracranial Hemorrhages | 1 | 2008 | 75 | 0.280 |
Why?
|
| Blood Pressure Determination | 3 | 2015 | 106 | 0.280 |
Why?
|
| Middle Aged | 17 | 2021 | 26605 | 0.280 |
Why?
|
| Texas | 13 | 2021 | 3583 | 0.270 |
Why?
|
| Follow-Up Studies | 7 | 2024 | 5127 | 0.270 |
Why?
|
| Infusions, Intravenous | 7 | 2020 | 547 | 0.270 |
Why?
|
| Incidence | 9 | 2022 | 3132 | 0.270 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2022 | 1689 | 0.270 |
Why?
|
| Research Design | 3 | 2018 | 689 | 0.270 |
Why?
|
| Bradycardia | 2 | 2018 | 60 | 0.270 |
Why?
|
| Hemostatic Techniques | 1 | 2006 | 32 | 0.270 |
Why?
|
| Brain Diseases | 2 | 2002 | 299 | 0.270 |
Why?
|
| Seizures | 5 | 2005 | 874 | 0.260 |
Why?
|
| Bandages | 1 | 2006 | 45 | 0.260 |
Why?
|
| Watchful Waiting | 3 | 2023 | 69 | 0.260 |
Why?
|
| Head | 3 | 2015 | 103 | 0.260 |
Why?
|
| Fetal Distress | 2 | 2016 | 11 | 0.260 |
Why?
|
| Zika Virus | 2 | 2019 | 143 | 0.260 |
Why?
|
| Constriction, Pathologic | 2 | 2020 | 242 | 0.260 |
Why?
|
| Critical Care | 3 | 2018 | 657 | 0.260 |
Why?
|
| Patient Readmission | 1 | 2009 | 383 | 0.260 |
Why?
|
| Pneumonia | 1 | 2009 | 323 | 0.260 |
Why?
|
| Premenopause | 2 | 1996 | 31 | 0.260 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 356 | 0.250 |
Why?
|
| Electrocoagulation | 2 | 2016 | 36 | 0.250 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2019 | 314 | 0.250 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2016 | 18 | 0.250 |
Why?
|
| Cesarean Section, Repeat | 2 | 2024 | 8 | 0.250 |
Why?
|
| Blood Component Transfusion | 3 | 2021 | 55 | 0.250 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2005 | 17 | 0.240 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1259 | 0.240 |
Why?
|
| Labor Presentation | 2 | 2022 | 10 | 0.240 |
Why?
|
| Diagnostic Imaging | 2 | 2018 | 275 | 0.240 |
Why?
|
| Extraembryonic Membranes | 2 | 2020 | 14 | 0.240 |
Why?
|
| Medical Records | 2 | 2009 | 189 | 0.240 |
Why?
|
| Posture | 2 | 2005 | 138 | 0.240 |
Why?
|
| Fetal Blood | 5 | 2019 | 176 | 0.240 |
Why?
|
| Conservative Treatment | 1 | 2025 | 35 | 0.240 |
Why?
|
| Fertilization in Vitro | 3 | 2021 | 147 | 0.230 |
Why?
|
| Light Coagulation | 5 | 2023 | 24 | 0.230 |
Why?
|
| Heart Rate | 7 | 2012 | 582 | 0.230 |
Why?
|
| Sacrococcygeal Region | 1 | 2024 | 32 | 0.230 |
Why?
|
| Anesthesia, General | 3 | 2024 | 118 | 0.230 |
Why?
|
| Oxygen Consumption | 3 | 1994 | 304 | 0.230 |
Why?
|
| Twins | 4 | 2021 | 69 | 0.230 |
Why?
|
| Risk Assessment | 7 | 2020 | 3428 | 0.220 |
Why?
|
| Tocolytic Agents | 2 | 2021 | 12 | 0.220 |
Why?
|
| Bronchodilator Agents | 1 | 2005 | 153 | 0.220 |
Why?
|
| Logistic Models | 5 | 2021 | 1800 | 0.220 |
Why?
|
| Oxygen | 3 | 2005 | 552 | 0.220 |
Why?
|
| Sutures | 1 | 2024 | 65 | 0.220 |
Why?
|
| Gynecology | 3 | 2018 | 123 | 0.220 |
Why?
|
| Infant, Premature | 4 | 2023 | 812 | 0.210 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2020 | 64 | 0.210 |
Why?
|
| Intracranial Hypertension | 1 | 2005 | 120 | 0.210 |
Why?
|
| Vibration | 1 | 2003 | 31 | 0.210 |
Why?
|
| Acidosis | 3 | 2021 | 93 | 0.210 |
Why?
|
| Surgical Instruments | 2 | 2021 | 56 | 0.210 |
Why?
|
| Cardiac Output | 4 | 2016 | 170 | 0.210 |
Why?
|
| Pressure Ulcer | 1 | 2023 | 74 | 0.210 |
Why?
|
| Pilot Projects | 5 | 2016 | 1367 | 0.210 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 287 | 0.210 |
Why?
|
| Acoustic Stimulation | 1 | 2003 | 85 | 0.210 |
Why?
|
| Fetal Monitoring | 3 | 2022 | 56 | 0.210 |
Why?
|
| Clinical Trials as Topic | 4 | 2017 | 1086 | 0.200 |
Why?
|
| Echoencephalography | 2 | 1999 | 23 | 0.200 |
Why?
|
| Hip Dislocation, Congenital | 1 | 2023 | 18 | 0.200 |
Why?
|
| Body Mass Index | 3 | 2020 | 1556 | 0.200 |
Why?
|
| Blood Gas Analysis | 2 | 2021 | 83 | 0.200 |
Why?
|
| Infant, Premature, Diseases | 2 | 2017 | 242 | 0.200 |
Why?
|
| Headache | 3 | 1999 | 107 | 0.200 |
Why?
|
| Depression, Postpartum | 1 | 2023 | 53 | 0.200 |
Why?
|
| Operative Time | 2 | 2025 | 171 | 0.200 |
Why?
|
| Meconium | 3 | 1997 | 11 | 0.200 |
Why?
|
| Feasibility Studies | 2 | 2017 | 745 | 0.200 |
Why?
|
| Corpus Callosum | 1 | 2022 | 95 | 0.200 |
Why?
|
| Child Development | 1 | 2025 | 267 | 0.200 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2022 | 61 | 0.200 |
Why?
|
| Intestinal Atresia | 1 | 2022 | 19 | 0.190 |
Why?
|
| Longitudinal Studies | 6 | 2021 | 1322 | 0.190 |
Why?
|
| Pregnancy, Ectopic | 1 | 2022 | 23 | 0.190 |
Why?
|
| Survival Analysis | 4 | 2021 | 1491 | 0.190 |
Why?
|
| Subcutaneous Fat | 1 | 2022 | 29 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2020 | 57 | 0.190 |
Why?
|
| Blood Glucose | 2 | 2019 | 1135 | 0.190 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2022 | 1103 | 0.190 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2003 | 109 | 0.190 |
Why?
|
| Clinical Decision-Making | 3 | 2019 | 265 | 0.190 |
Why?
|
| Dilatation | 1 | 2022 | 64 | 0.190 |
Why?
|
| Mullerian Ducts | 1 | 2021 | 33 | 0.190 |
Why?
|
| Verapamil | 3 | 1991 | 55 | 0.190 |
Why?
|
| Abdomen | 2 | 2020 | 127 | 0.190 |
Why?
|
| Abdominal Wall | 1 | 2021 | 32 | 0.180 |
Why?
|
| Chronic Disease | 4 | 2014 | 1179 | 0.180 |
Why?
|
| Heart Atria | 3 | 2019 | 315 | 0.180 |
Why?
|
| Parity | 5 | 2017 | 78 | 0.180 |
Why?
|
| Receptor Activity-Modifying Protein 1 | 2 | 2022 | 13 | 0.180 |
Why?
|
| Radiology, Interventional | 2 | 2018 | 28 | 0.180 |
Why?
|
| Rhombencephalon | 1 | 2021 | 46 | 0.180 |
Why?
|
| Databases as Topic | 1 | 2021 | 71 | 0.180 |
Why?
|
| Multivariate Analysis | 4 | 2020 | 1422 | 0.180 |
Why?
|
| Hemorrhage | 3 | 2022 | 468 | 0.180 |
Why?
|
| Biological Specimen Banks | 1 | 2021 | 51 | 0.180 |
Why?
|
| Neonatology | 2 | 2018 | 53 | 0.180 |
Why?
|
| Varicose Veins | 1 | 2021 | 29 | 0.180 |
Why?
|
| Fetal Movement | 2 | 2021 | 14 | 0.180 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 6 | 2022 | 38 | 0.180 |
Why?
|
| Nitric Oxide | 3 | 2016 | 445 | 0.180 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2024 | 314 | 0.170 |
Why?
|
| Scalp | 2 | 2011 | 57 | 0.170 |
Why?
|
| Maternal-Child Health Services | 2 | 2019 | 13 | 0.170 |
Why?
|
| Survival Rate | 4 | 2022 | 2036 | 0.170 |
Why?
|
| Anemia, Hemolytic | 2 | 2019 | 30 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 178 | 0.170 |
Why?
|
| Urology | 2 | 2018 | 75 | 0.170 |
Why?
|
| Vesicular Transport Proteins | 1 | 2021 | 120 | 0.170 |
Why?
|
| Intraoperative Complications | 1 | 2021 | 172 | 0.170 |
Why?
|
| Edema | 2 | 2022 | 135 | 0.170 |
Why?
|
| Anemia, Neonatal | 1 | 2019 | 8 | 0.170 |
Why?
|
| Patient Selection | 3 | 2021 | 688 | 0.170 |
Why?
|
| Calcitonin Receptor-Like Protein | 2 | 2016 | 22 | 0.170 |
Why?
|
| Oxytocics | 4 | 2018 | 28 | 0.170 |
Why?
|
| Anxiety | 2 | 2023 | 941 | 0.160 |
Why?
|
| Aftercare | 1 | 2021 | 147 | 0.160 |
Why?
|
| Emergency Treatment | 1 | 2020 | 86 | 0.160 |
Why?
|
| Probability | 3 | 2005 | 323 | 0.160 |
Why?
|
| Ductus Arteriosus | 1 | 2020 | 62 | 0.160 |
Why?
|
| Morbidity | 2 | 2023 | 246 | 0.160 |
Why?
|
| Ligation | 2 | 2020 | 135 | 0.160 |
Why?
|
| Remission, Spontaneous | 1 | 2019 | 69 | 0.160 |
Why?
|
| Referral and Consultation | 2 | 2022 | 542 | 0.160 |
Why?
|
| Social Media | 1 | 2021 | 105 | 0.160 |
Why?
|
| Placenta Growth Factor | 1 | 2019 | 11 | 0.160 |
Why?
|
| Risk | 3 | 2021 | 754 | 0.160 |
Why?
|
| Maternal Age | 6 | 2017 | 134 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 19 | 0.160 |
Why?
|
| Multicenter Studies as Topic | 3 | 2023 | 275 | 0.160 |
Why?
|
| Infant Care | 1 | 2019 | 46 | 0.160 |
Why?
|
| Transfusion Medicine | 1 | 2018 | 2 | 0.160 |
Why?
|
| Spectrin | 1 | 2019 | 63 | 0.160 |
Why?
|
| Fetal Hemoglobin | 1 | 2019 | 28 | 0.160 |
Why?
|
| Trophoblasts | 2 | 2017 | 113 | 0.160 |
Why?
|
| Pressure | 2 | 2011 | 117 | 0.160 |
Why?
|
| Placentation | 2 | 2019 | 55 | 0.160 |
Why?
|
| Preoperative Care | 1 | 2021 | 354 | 0.160 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 1 | 2018 | 9 | 0.160 |
Why?
|
| Bicarbonates | 1 | 2019 | 98 | 0.160 |
Why?
|
| Iatrogenic Disease | 4 | 2022 | 133 | 0.160 |
Why?
|
| Nomograms | 1 | 2019 | 36 | 0.150 |
Why?
|
| Orbit | 1 | 1999 | 102 | 0.150 |
Why?
|
| Gonadal Steroid Hormones | 2 | 1999 | 88 | 0.150 |
Why?
|
| Hemodilution | 2 | 1998 | 15 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2018 | 225 | 0.150 |
Why?
|
| Shock | 1 | 2020 | 90 | 0.150 |
Why?
|
| Hospitals, Low-Volume | 1 | 2018 | 30 | 0.150 |
Why?
|
| Matrix Metalloproteinase 8 | 1 | 2018 | 15 | 0.150 |
Why?
|
| Perinatology | 1 | 2018 | 32 | 0.150 |
Why?
|
| Movement Disorders | 1 | 2021 | 220 | 0.150 |
Why?
|
| Tachycardia | 1 | 2018 | 70 | 0.150 |
Why?
|
| Meningocele | 1 | 2018 | 19 | 0.150 |
Why?
|
| Arginine | 2 | 2015 | 332 | 0.150 |
Why?
|
| Registries | 4 | 2020 | 1422 | 0.150 |
Why?
|
| Child | 7 | 2023 | 24354 | 0.150 |
Why?
|
| Labor Stage, First | 2 | 2022 | 7 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2022 | 680 | 0.150 |
Why?
|
| Angiotensin II | 1 | 2019 | 163 | 0.150 |
Why?
|
| Administration, Oral | 1 | 2020 | 680 | 0.150 |
Why?
|
| Urologic Surgical Procedures | 1 | 2018 | 58 | 0.150 |
Why?
|
| Malpractice | 2 | 2008 | 55 | 0.150 |
Why?
|
| Pregnancy Reduction, Multifetal | 3 | 2022 | 20 | 0.150 |
Why?
|
| Asthma | 1 | 2005 | 749 | 0.150 |
Why?
|
| Liability, Legal | 1 | 2018 | 44 | 0.150 |
Why?
|
| Endometrial Ablation Techniques | 1 | 2017 | 3 | 0.150 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1881 | 0.150 |
Why?
|
| Patient Admission | 1 | 2019 | 185 | 0.140 |
Why?
|
| Isotonic Solutions | 2 | 2017 | 35 | 0.140 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2020 | 366 | 0.140 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 126 | 0.140 |
Why?
|
| Urinary Bladder Diseases | 1 | 2017 | 35 | 0.140 |
Why?
|
| Depression | 2 | 2023 | 1215 | 0.140 |
Why?
|
| Lactic Acid | 1 | 2018 | 154 | 0.140 |
Why?
|
| Intestines | 1 | 2021 | 574 | 0.140 |
Why?
|
| Norwood Procedures | 1 | 2019 | 101 | 0.140 |
Why?
|
| Epidemiologic Methods | 1 | 2017 | 110 | 0.140 |
Why?
|
| Hypothermia | 1 | 2018 | 57 | 0.140 |
Why?
|
| Peer Review | 2 | 2015 | 39 | 0.140 |
Why?
|
| Disease Progression | 2 | 2019 | 2044 | 0.140 |
Why?
|
| Renal Insufficiency | 2 | 2021 | 236 | 0.140 |
Why?
|
| Congenital Abnormalities | 2 | 2018 | 255 | 0.140 |
Why?
|
| Insulin-Secreting Cells | 1 | 2019 | 149 | 0.140 |
Why?
|
| Decision Support Techniques | 2 | 2022 | 293 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2018 | 646 | 0.140 |
Why?
|
| Wounds and Injuries | 2 | 1999 | 368 | 0.140 |
Why?
|
| Hernia, Diaphragmatic | 3 | 2014 | 98 | 0.140 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2017 | 65 | 0.140 |
Why?
|
| Symptom Assessment | 2 | 2019 | 100 | 0.140 |
Why?
|
| Pregnancy, Multiple | 2 | 1998 | 47 | 0.140 |
Why?
|
| Reproductive Techniques, Assisted | 1 | 2017 | 70 | 0.140 |
Why?
|
| Observer Variation | 2 | 2017 | 299 | 0.140 |
Why?
|
| Anesthesiology | 1 | 2018 | 94 | 0.140 |
Why?
|
| Adipokines | 1 | 2017 | 58 | 0.140 |
Why?
|
| Pulmonary Veins | 1 | 2019 | 161 | 0.140 |
Why?
|
| Organ Size | 4 | 2025 | 425 | 0.140 |
Why?
|
| Blood Patch, Epidural | 1 | 2016 | 6 | 0.140 |
Why?
|
| Models, Anatomic | 1 | 2018 | 99 | 0.140 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 68 | 0.140 |
Why?
|
| Pericardium | 1 | 2017 | 81 | 0.130 |
Why?
|
| Surgical Stapling | 1 | 2016 | 19 | 0.130 |
Why?
|
| Emigrants and Immigrants | 1 | 2019 | 143 | 0.130 |
Why?
|
| Wounds, Penetrating | 1 | 1997 | 141 | 0.130 |
Why?
|
| Genetic Testing | 2 | 2024 | 998 | 0.130 |
Why?
|
| Liver | 4 | 2019 | 1736 | 0.130 |
Why?
|
| Gadolinium | 1 | 2017 | 104 | 0.130 |
Why?
|
| Sepsis | 1 | 2021 | 478 | 0.130 |
Why?
|
| Oxytocin | 3 | 2018 | 69 | 0.130 |
Why?
|
| Analysis of Variance | 7 | 2010 | 1010 | 0.130 |
Why?
|
| Quality Improvement | 2 | 2022 | 639 | 0.130 |
Why?
|
| Anesthetics | 1 | 2017 | 80 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2015 | 217 | 0.130 |
Why?
|
| Epidemics | 1 | 2017 | 54 | 0.130 |
Why?
|
| Birth Rate | 1 | 2016 | 16 | 0.130 |
Why?
|
| Heart Neoplasms | 1 | 2017 | 101 | 0.130 |
Why?
|
| Head and Neck Neoplasms | 1 | 2021 | 489 | 0.130 |
Why?
|
| Algorithms | 3 | 2022 | 1606 | 0.130 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2018 | 223 | 0.130 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2017 | 63 | 0.130 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2016 | 97 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2016 | 111 | 0.130 |
Why?
|
| Maternal-Fetal Relations | 1 | 2016 | 14 | 0.130 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 128 | 0.130 |
Why?
|
| Breath Tests | 1 | 2016 | 178 | 0.130 |
Why?
|
| Abortion, Induced | 2 | 2013 | 74 | 0.130 |
Why?
|
| Neuroimaging | 1 | 2019 | 334 | 0.130 |
Why?
|
| Virus Diseases | 1 | 2019 | 279 | 0.130 |
Why?
|
| Postnatal Care | 3 | 2022 | 51 | 0.130 |
Why?
|
| Complement C4a | 1 | 2015 | 4 | 0.130 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2016 | 139 | 0.130 |
Why?
|
| Hospital Mortality | 2 | 2018 | 1020 | 0.130 |
Why?
|
| Foreign-Body Migration | 1 | 2016 | 72 | 0.130 |
Why?
|
| Data Collection | 1 | 2017 | 382 | 0.130 |
Why?
|
| Ovary | 1 | 2018 | 379 | 0.130 |
Why?
|
| Complement Factor B | 1 | 2015 | 11 | 0.130 |
Why?
|
| Complement C5a | 1 | 2015 | 24 | 0.130 |
Why?
|
| Endothelin Receptor Antagonists | 1 | 2015 | 14 | 0.120 |
Why?
|
| Length of Stay | 3 | 2021 | 1308 | 0.120 |
Why?
|
| Abnormalities, Multiple | 4 | 2015 | 956 | 0.120 |
Why?
|
| Dyslipidemias | 1 | 2018 | 232 | 0.120 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2016 | 37 | 0.120 |
Why?
|
| Glucose Tolerance Test | 3 | 2019 | 208 | 0.120 |
Why?
|
| Hematocrit | 4 | 2017 | 111 | 0.120 |
Why?
|
| Quality Control | 1 | 2015 | 119 | 0.120 |
Why?
|
| Lower Urinary Tract Symptoms | 1 | 2015 | 31 | 0.120 |
Why?
|
| Uterine Artery Embolization | 1 | 2015 | 4 | 0.120 |
Why?
|
| Cell Lineage | 1 | 2017 | 338 | 0.120 |
Why?
|
| Peptides, Cyclic | 1 | 2015 | 52 | 0.120 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 158 | 0.120 |
Why?
|
| Arm | 1 | 2015 | 81 | 0.120 |
Why?
|
| Models, Animal | 2 | 2017 | 461 | 0.120 |
Why?
|
| Syndrome | 2 | 2019 | 1118 | 0.120 |
Why?
|
| Wounds, Nonpenetrating | 1 | 1997 | 215 | 0.120 |
Why?
|
| Hysteroscopy | 1 | 2015 | 11 | 0.120 |
Why?
|
| Bayes Theorem | 1 | 2016 | 283 | 0.120 |
Why?
|
| Perineum | 2 | 2021 | 48 | 0.120 |
Why?
|
| Renal Veins | 1 | 2015 | 36 | 0.120 |
Why?
|
| Suture Techniques | 1 | 2016 | 196 | 0.120 |
Why?
|
| Congresses as Topic | 1 | 2016 | 173 | 0.120 |
Why?
|
| Oximetry | 1 | 2016 | 162 | 0.120 |
Why?
|
| Rh Isoimmunization | 3 | 2024 | 28 | 0.120 |
Why?
|
| Urinary Fistula | 1 | 2015 | 20 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2016 | 78 | 0.120 |
Why?
|
| Urethra | 1 | 2015 | 84 | 0.120 |
Why?
|
| Echocardiography, Doppler | 2 | 1995 | 171 | 0.120 |
Why?
|
| Reproduction | 1 | 2017 | 238 | 0.120 |
Why?
|
| International Cooperation | 1 | 2015 | 157 | 0.120 |
Why?
|
| Mitral Valve | 1 | 2016 | 248 | 0.120 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 356 | 0.120 |
Why?
|
| Interinstitutional Relations | 1 | 2014 | 20 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 84 | 0.110 |
Why?
|
| Tidal Volume | 1 | 2014 | 38 | 0.110 |
Why?
|
| Analgesics, Opioid | 2 | 2021 | 414 | 0.110 |
Why?
|
| Hyperoxia | 1 | 2016 | 129 | 0.110 |
Why?
|
| Live Birth | 3 | 2020 | 55 | 0.110 |
Why?
|
| Publishing | 1 | 2015 | 109 | 0.110 |
Why?
|
| Italy | 1 | 2014 | 97 | 0.110 |
Why?
|
| Animals | 9 | 2023 | 34067 | 0.110 |
Why?
|
| Progesterone | 2 | 1999 | 624 | 0.110 |
Why?
|
| Retroperitoneal Fibrosis | 1 | 1993 | 3 | 0.110 |
Why?
|
| Arteriovenous Anastomosis | 1 | 2013 | 5 | 0.110 |
Why?
|
| Insulin | 1 | 2019 | 1200 | 0.110 |
Why?
|
| Bupivacaine | 1 | 2013 | 23 | 0.110 |
Why?
|
| Tocolysis | 1 | 1993 | 5 | 0.110 |
Why?
|
| Hypoxia | 1 | 2015 | 248 | 0.110 |
Why?
|
| Glucocorticoids | 1 | 2016 | 380 | 0.110 |
Why?
|
| Version, Fetal | 1 | 1993 | 6 | 0.110 |
Why?
|
| Nitroglycerin | 1 | 1993 | 22 | 0.110 |
Why?
|
| Diagnostic Techniques, Surgical | 1 | 2013 | 2 | 0.110 |
Why?
|
| Contrast Media | 1 | 2017 | 470 | 0.110 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1993 | 30 | 0.110 |
Why?
|
| Regression Analysis | 4 | 2020 | 777 | 0.110 |
Why?
|
| Triplets | 2 | 2012 | 11 | 0.110 |
Why?
|
| Morphine | 1 | 2013 | 88 | 0.110 |
Why?
|
| Enzyme Inhibitors | 2 | 2015 | 578 | 0.110 |
Why?
|
| Sheep, Domestic | 1 | 2013 | 17 | 0.110 |
Why?
|
| Time-to-Treatment | 1 | 2015 | 185 | 0.110 |
Why?
|
| Health Services Accessibility | 1 | 2019 | 605 | 0.110 |
Why?
|
| Fetal Organ Maturity | 1 | 2013 | 14 | 0.110 |
Why?
|
| Aneurysm, Ruptured | 1 | 1993 | 35 | 0.110 |
Why?
|
| Virus Replication | 1 | 2017 | 610 | 0.110 |
Why?
|
| Tissue Adhesives | 1 | 2013 | 36 | 0.100 |
Why?
|
| Proteinuria | 4 | 2002 | 101 | 0.100 |
Why?
|
| Cooperative Behavior | 1 | 2014 | 218 | 0.100 |
Why?
|
| Venous Thrombosis | 1 | 2015 | 181 | 0.100 |
Why?
|
| Erythroblastosis, Fetal | 4 | 1997 | 27 | 0.100 |
Why?
|
| Methotrexate | 1 | 2015 | 341 | 0.100 |
Why?
|
| Anesthetics, Local | 1 | 2013 | 83 | 0.100 |
Why?
|
| Linear Models | 4 | 2013 | 667 | 0.100 |
Why?
|
| Rabbits | 3 | 2023 | 709 | 0.100 |
Why?
|
| Odds Ratio | 3 | 2021 | 1251 | 0.100 |
Why?
|
| Nisoldipine | 1 | 1992 | 1 | 0.100 |
Why?
|
| Vaccination | 1 | 2017 | 954 | 0.100 |
Why?
|
| Image Enhancement | 1 | 2013 | 163 | 0.100 |
Why?
|
| Retinal Vessels | 1 | 1992 | 73 | 0.100 |
Why?
|
| Frontal Bone | 1 | 2012 | 16 | 0.100 |
Why?
|
| Peptide Fragments | 1 | 2016 | 778 | 0.100 |
Why?
|
| Occipital Bone | 1 | 2012 | 21 | 0.100 |
Why?
|
| Cephalometry | 1 | 2012 | 33 | 0.100 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2019 | 626 | 0.100 |
Why?
|
| Secondary Prevention | 1 | 2013 | 216 | 0.100 |
Why?
|
| Crown-Rump Length | 3 | 2014 | 6 | 0.100 |
Why?
|
| Hospitals | 1 | 2014 | 388 | 0.100 |
Why?
|
| Collagen | 1 | 2013 | 315 | 0.100 |
Why?
|
| Uterine Contraction | 3 | 2019 | 28 | 0.090 |
Why?
|
| Vision Disorders | 1 | 1993 | 211 | 0.090 |
Why?
|
| Inflammation | 1 | 2018 | 1428 | 0.090 |
Why?
|
| Manometry | 1 | 2011 | 48 | 0.090 |
Why?
|
| Respiration | 1 | 1991 | 120 | 0.090 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 727 | 0.090 |
Why?
|
| Carcinoma | 1 | 1993 | 285 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 169 | 0.090 |
Why?
|
| Microcephaly | 3 | 2019 | 330 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2021 | 427 | 0.090 |
Why?
|
| Biomarkers | 2 | 2017 | 3049 | 0.090 |
Why?
|
| Retina | 1 | 1993 | 450 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 4344 | 0.080 |
Why?
|
| Ascitic Fluid | 1 | 1990 | 30 | 0.080 |
Why?
|
| Abdominal Neoplasms | 1 | 1990 | 33 | 0.080 |
Why?
|
| Heart | 1 | 1994 | 708 | 0.080 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 2 | 2022 | 12 | 0.080 |
Why?
|
| Receptor Activity-Modifying Protein 3 | 2 | 2022 | 12 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2017 | 1888 | 0.080 |
Why?
|
| Models, Biological | 1 | 2014 | 1455 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2010 | 152 | 0.080 |
Why?
|
| Eikenella corrodens | 1 | 2008 | 4 | 0.080 |
Why?
|
| Body Piercing | 1 | 2008 | 4 | 0.080 |
Why?
|
| Postoperative Period | 2 | 2020 | 330 | 0.080 |
Why?
|
| Placental Circulation | 2 | 2020 | 24 | 0.080 |
Why?
|
| Term Birth | 1 | 2008 | 32 | 0.080 |
Why?
|
| Compensation and Redress | 1 | 2008 | 12 | 0.080 |
Why?
|
| Time Factors | 5 | 2018 | 6275 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2021 | 509 | 0.080 |
Why?
|
| Norepinephrine | 3 | 2001 | 175 | 0.070 |
Why?
|
| Counseling | 2 | 2022 | 216 | 0.070 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2008 | 87 | 0.070 |
Why?
|
| Phenotype | 2 | 2019 | 4252 | 0.070 |
Why?
|
| Lacerations | 1 | 2008 | 34 | 0.070 |
Why?
|
| Muscle Contraction | 3 | 1999 | 188 | 0.070 |
Why?
|
| Dilatation, Pathologic | 2 | 2021 | 92 | 0.070 |
Why?
|
| Prostaglandin Endoperoxides, Synthetic | 3 | 1996 | 6 | 0.070 |
Why?
|
| Aging | 1 | 2014 | 1166 | 0.070 |
Why?
|
| Thromboxane A2 | 3 | 1996 | 19 | 0.070 |
Why?
|
| Mothers | 2 | 2023 | 351 | 0.070 |
Why?
|
| T-Phages | 1 | 1987 | 3 | 0.070 |
Why?
|
| Resuscitation | 2 | 2022 | 251 | 0.070 |
Why?
|
| Thymidylate Synthase | 1 | 1987 | 22 | 0.070 |
Why?
|
| Utah | 1 | 2006 | 47 | 0.070 |
Why?
|
| Lipids | 2 | 2022 | 513 | 0.070 |
Why?
|
| Cells, Cultured | 3 | 2017 | 3038 | 0.070 |
Why?
|
| Diastole | 2 | 2000 | 170 | 0.070 |
Why?
|
| Endothelium, Vascular | 4 | 2015 | 520 | 0.070 |
Why?
|
| Cross-Sectional Studies | 3 | 2023 | 3411 | 0.070 |
Why?
|
| Pulse | 3 | 2004 | 29 | 0.060 |
Why?
|
| Societies, Medical | 2 | 2021 | 690 | 0.060 |
Why?
|
| Isometric Contraction | 2 | 1996 | 22 | 0.060 |
Why?
|
| Genital Neoplasms, Female | 1 | 1986 | 46 | 0.060 |
Why?
|
| Ascites | 1 | 1986 | 88 | 0.060 |
Why?
|
| Endothelins | 2 | 1996 | 8 | 0.060 |
Why?
|
| RNA Splicing | 1 | 1987 | 227 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2019 | 432 | 0.060 |
Why?
|
| Magnetoencephalography | 1 | 2005 | 33 | 0.060 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2005 | 29 | 0.060 |
Why?
|
| Sampling Studies | 1 | 2005 | 77 | 0.060 |
Why?
|
| Forms and Records Control | 1 | 2004 | 10 | 0.060 |
Why?
|
| Brazil | 2 | 2015 | 122 | 0.060 |
Why?
|
| Parvoviridae Infections | 1 | 2024 | 36 | 0.060 |
Why?
|
| Tensile Strength | 1 | 2024 | 40 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2019 | 1688 | 0.060 |
Why?
|
| Respiratory Function Tests | 1 | 2005 | 199 | 0.060 |
Why?
|
| Polyesters | 1 | 2024 | 39 | 0.060 |
Why?
|
| Anthropometry | 1 | 2005 | 197 | 0.060 |
Why?
|
| Materials Testing | 1 | 2024 | 73 | 0.060 |
Why?
|
| Risk Management | 1 | 2004 | 68 | 0.060 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2018 | 23 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2024 | 33 | 0.060 |
Why?
|
| Cerebral Ventricles | 1 | 2024 | 80 | 0.060 |
Why?
|
| Pulmonary Atresia | 1 | 2024 | 46 | 0.050 |
Why?
|
| HELLP Syndrome | 2 | 2021 | 18 | 0.050 |
Why?
|
| Vasospasm, Intracranial | 1 | 2003 | 18 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 1994 | 50 | 0.050 |
Why?
|
| Cervix Uteri | 1 | 2023 | 64 | 0.050 |
Why?
|
| Microarray Analysis | 1 | 2023 | 229 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2010 | 1085 | 0.050 |
Why?
|
| Cytomegalovirus Infections | 1 | 2024 | 218 | 0.050 |
Why?
|
| Acute Disease | 1 | 2005 | 1109 | 0.050 |
Why?
|
| Fetal Hypoxia | 1 | 2022 | 14 | 0.050 |
Why?
|
| Duodenal Obstruction | 1 | 2022 | 12 | 0.050 |
Why?
|
| Apamin | 1 | 2022 | 4 | 0.050 |
Why?
|
| Charybdotoxin | 1 | 2022 | 8 | 0.050 |
Why?
|
| Tertiary Care Centers | 1 | 2023 | 236 | 0.050 |
Why?
|
| Receptors, Calcitonin | 1 | 2022 | 21 | 0.050 |
Why?
|
| Maryland | 1 | 2021 | 30 | 0.050 |
Why?
|
| Social Class | 1 | 2023 | 190 | 0.050 |
Why?
|
| Dimerization | 1 | 2022 | 144 | 0.050 |
Why?
|
| Platelet Transfusion | 2 | 2019 | 53 | 0.050 |
Why?
|
| Clubfoot | 1 | 2021 | 19 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 1228 | 0.050 |
Why?
|
| Waist Circumference | 1 | 2021 | 90 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2001 | 46 | 0.050 |
Why?
|
| Biophysical Phenomena | 1 | 2021 | 39 | 0.050 |
Why?
|
| Intention to Treat Analysis | 1 | 2021 | 64 | 0.050 |
Why?
|
| Mental Health Services | 1 | 2024 | 256 | 0.050 |
Why?
|
| Patient Acuity | 1 | 2021 | 65 | 0.050 |
Why?
|
| Patient Preference | 1 | 2022 | 116 | 0.050 |
Why?
|
| Fourier Analysis | 1 | 2021 | 59 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2023 | 299 | 0.050 |
Why?
|
| Dextrans | 2 | 1991 | 45 | 0.050 |
Why?
|
| Encephalocele | 1 | 2021 | 51 | 0.040 |
Why?
|
| Guideline Adherence | 2 | 2017 | 380 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2001 | 186 | 0.040 |
Why?
|
| Pulmonary Edema | 1 | 2021 | 48 | 0.040 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2022 | 234 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2001 | 144 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2002 | 144 | 0.040 |
Why?
|
| Preoperative Period | 1 | 2020 | 86 | 0.040 |
Why?
|
| Potassium Chloride | 2 | 2001 | 54 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2021 | 102 | 0.040 |
Why?
|
| Rats | 2 | 2017 | 3676 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 307 | 0.040 |
Why?
|
| Ventricular Function, Left | 2 | 1995 | 505 | 0.040 |
Why?
|
| Colpotomy | 1 | 2020 | 6 | 0.040 |
Why?
|
| Delphi Technique | 1 | 2021 | 211 | 0.040 |
Why?
|
| Multigene Family | 1 | 2021 | 298 | 0.040 |
Why?
|
| Video Recording | 1 | 2021 | 182 | 0.040 |
Why?
|
| Heart Arrest | 1 | 2024 | 351 | 0.040 |
Why?
|
| APACHE | 1 | 2000 | 53 | 0.040 |
Why?
|
| Learning Curve | 1 | 2020 | 52 | 0.040 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2024 | 418 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 3688 | 0.040 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 62 | 0.040 |
Why?
|
| Systole | 1 | 2000 | 198 | 0.040 |
Why?
|
| Iliac Artery | 1 | 2020 | 93 | 0.040 |
Why?
|
| Scotoma | 1 | 1999 | 16 | 0.040 |
Why?
|
| Glasgow Coma Scale | 1 | 2000 | 207 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2003 | 459 | 0.040 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2019 | 16 | 0.040 |
Why?
|
| Choroid Plexus | 1 | 2019 | 23 | 0.040 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 240 | 0.040 |
Why?
|
| Information Dissemination | 1 | 2021 | 186 | 0.040 |
Why?
|
| Hemoglobin A | 1 | 2019 | 22 | 0.040 |
Why?
|
| Central America | 1 | 2019 | 21 | 0.040 |
Why?
|
| South America | 1 | 2019 | 39 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 2019 | 74 | 0.040 |
Why?
|
| Ventriculostomy | 1 | 2019 | 35 | 0.040 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2019 | 67 | 0.040 |
Why?
|
| Acid-Base Imbalance | 1 | 2019 | 27 | 0.040 |
Why?
|
| Cause of Death | 2 | 2008 | 473 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 59 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2021 | 195 | 0.040 |
Why?
|
| Siblings | 1 | 2019 | 197 | 0.040 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2019 | 50 | 0.040 |
Why?
|
| Swine | 1 | 2022 | 1177 | 0.040 |
Why?
|
| Workflow | 1 | 2019 | 117 | 0.040 |
Why?
|
| Bilirubin | 2 | 1997 | 123 | 0.040 |
Why?
|
| Plasma | 1 | 2019 | 98 | 0.040 |
Why?
|
| Misoprostol | 2 | 2009 | 26 | 0.040 |
Why?
|
| Amniocentesis | 1 | 2019 | 77 | 0.040 |
Why?
|
| Hypertrophy | 1 | 2018 | 102 | 0.040 |
Why?
|
| Portal Vein | 1 | 2019 | 94 | 0.040 |
Why?
|
| Mitral Valve Stenosis | 1 | 2018 | 34 | 0.040 |
Why?
|
| Mexico | 1 | 2019 | 182 | 0.040 |
Why?
|
| Lipolysis | 1 | 2018 | 79 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 307 | 0.040 |
Why?
|
| Trial of Labor | 1 | 2018 | 21 | 0.040 |
Why?
|
| Politics | 1 | 2019 | 58 | 0.040 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 24 | 0.040 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 35 | 0.040 |
Why?
|
| Colombia | 1 | 2018 | 48 | 0.040 |
Why?
|
| Calcium | 3 | 2016 | 1100 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2018 | 77 | 0.040 |
Why?
|
| Urodynamics | 1 | 2017 | 40 | 0.040 |
Why?
|
| Meningitis | 1 | 2018 | 98 | 0.040 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2018 | 77 | 0.040 |
Why?
|
| Constriction | 1 | 2017 | 50 | 0.040 |
Why?
|
| Christianity | 1 | 1997 | 14 | 0.040 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 53 | 0.040 |
Why?
|
| MEDLINE | 1 | 2017 | 20 | 0.040 |
Why?
|
| Blood Transfusion, Autologous | 1 | 1997 | 34 | 0.040 |
Why?
|
| Rupture | 1 | 1997 | 32 | 0.040 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 94 | 0.040 |
Why?
|
| Patient Positioning | 1 | 2018 | 54 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 197 | 0.040 |
Why?
|
| Hepatitis B | 1 | 2019 | 159 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2017 | 87 | 0.030 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 51 | 0.030 |
Why?
|
| Mass Screening | 1 | 2023 | 781 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2019 | 442 | 0.030 |
Why?
|
| Equipment Design | 1 | 1999 | 586 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 1999 | 357 | 0.030 |
Why?
|
| United Kingdom | 1 | 2017 | 189 | 0.030 |
Why?
|
| Hematoma, Subdural | 1 | 1997 | 20 | 0.030 |
Why?
|
| Giant Cells | 1 | 2017 | 34 | 0.030 |
Why?
|
| beta 2-Microglobulin | 1 | 2016 | 34 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2017 | 149 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 231 | 0.030 |
Why?
|
| Adipocytes | 1 | 2017 | 137 | 0.030 |
Why?
|
| Osmolar Concentration | 1 | 2016 | 176 | 0.030 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 241 | 0.030 |
Why?
|
| Pain Management | 1 | 2018 | 175 | 0.030 |
Why?
|
| Toll-Like Receptors | 1 | 2017 | 84 | 0.030 |
Why?
|
| Gravidity | 1 | 2016 | 10 | 0.030 |
Why?
|
| Menorrhagia | 1 | 2017 | 74 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 1997 | 355 | 0.030 |
Why?
|
| Breech Presentation | 1 | 2016 | 20 | 0.030 |
Why?
|
| Population | 1 | 2016 | 21 | 0.030 |
Why?
|
| Chlorides | 1 | 2016 | 106 | 0.030 |
Why?
|
| Maternal Exposure | 1 | 2018 | 148 | 0.030 |
Why?
|
| Liposomes | 1 | 2017 | 174 | 0.030 |
Why?
|
| Global Health | 1 | 2021 | 560 | 0.030 |
Why?
|
| Calcinosis | 1 | 2018 | 176 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2017 | 107 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2017 | 287 | 0.030 |
Why?
|
| Bradykinin | 1 | 2016 | 59 | 0.030 |
Why?
|
| Intraocular Pressure | 1 | 1997 | 144 | 0.030 |
Why?
|
| Emergencies | 1 | 2017 | 172 | 0.030 |
Why?
|
| Informed Consent | 1 | 1999 | 334 | 0.030 |
Why?
|
| Pedigree | 1 | 2019 | 1605 | 0.030 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1997 | 115 | 0.030 |
Why?
|
| Receptor Activity-Modifying Proteins | 1 | 2015 | 16 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 129 | 0.030 |
Why?
|
| Infant, Extremely Premature | 1 | 2016 | 84 | 0.030 |
Why?
|
| DNA | 1 | 2001 | 1595 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2019 | 543 | 0.030 |
Why?
|
| Dengue | 1 | 2017 | 113 | 0.030 |
Why?
|
| Dengue Virus | 1 | 2017 | 127 | 0.030 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 17 | 0.030 |
Why?
|
| Fetomaternal Transfusion | 1 | 1995 | 2 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 2015 | 89 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2016 | 219 | 0.030 |
Why?
|
| Hydralazine | 1 | 1995 | 8 | 0.030 |
Why?
|
| Dihydropyridines | 1 | 1995 | 8 | 0.030 |
Why?
|
| Ligands | 1 | 2017 | 531 | 0.030 |
Why?
|
| Budd-Chiari Syndrome | 1 | 1995 | 7 | 0.030 |
Why?
|
| Sodium | 1 | 2016 | 295 | 0.030 |
Why?
|
| Pregnant Women | 1 | 2016 | 142 | 0.030 |
Why?
|
| Lipid Peroxides | 1 | 1995 | 15 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2016 | 94 | 0.030 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2024 | 1113 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2815 | 0.030 |
Why?
|
| Thrombolytic Therapy | 1 | 1997 | 208 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2015 | 80 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1995 | 27 | 0.030 |
Why?
|
| Phenytoin | 1 | 1995 | 64 | 0.030 |
Why?
|
| Estrogen Replacement Therapy | 1 | 1995 | 44 | 0.030 |
Why?
|
| Tamoxifen | 1 | 1996 | 363 | 0.030 |
Why?
|
| France | 1 | 2015 | 80 | 0.030 |
Why?
|
| Trans-Activators | 1 | 2019 | 800 | 0.030 |
Why?
|
| Hepatitis C | 1 | 2019 | 366 | 0.030 |
Why?
|
| Estriol | 2 | 2008 | 7 | 0.030 |
Why?
|
| Ventricular Pressure | 1 | 1994 | 41 | 0.030 |
Why?
|
| Serotonin | 1 | 1996 | 229 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 695 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 126 | 0.030 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 1995 | 53 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2017 | 540 | 0.030 |
Why?
|
| Pyelonephritis | 1 | 1994 | 26 | 0.030 |
Why?
|
| Blood Specimen Collection | 1 | 1994 | 49 | 0.030 |
Why?
|
| Renal Replacement Therapy | 1 | 2015 | 142 | 0.030 |
Why?
|
| Internship and Residency | 1 | 2004 | 1175 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1231 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2022 | 1533 | 0.030 |
Why?
|
| Lower Extremity | 1 | 2016 | 181 | 0.030 |
Why?
|
| Hypotension | 1 | 2016 | 184 | 0.030 |
Why?
|
| Uterine Inertia | 1 | 2013 | 4 | 0.030 |
Why?
|
| Terminology as Topic | 1 | 2015 | 222 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2749 | 0.030 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 1993 | 19 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 616 | 0.030 |
Why?
|
| Ultrasonics | 1 | 1993 | 37 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1993 | 253 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1993 | 55 | 0.030 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 1993 | 28 | 0.030 |
Why?
|
| Aortic Valve | 1 | 2016 | 441 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2018 | 662 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 585 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2016 | 1615 | 0.030 |
Why?
|
| Herniorrhaphy | 1 | 2013 | 82 | 0.030 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1993 | 77 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 171 | 0.030 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 333 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 1029 | 0.020 |
Why?
|
| Hand Strength | 2 | 2002 | 39 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1993 | 94 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 470 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1994 | 1162 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2016 | 769 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2016 | 712 | 0.020 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 106 | 0.020 |
Why?
|
| Mutation | 2 | 2019 | 5821 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 1994 | 440 | 0.020 |
Why?
|
| Obesity | 1 | 2022 | 2262 | 0.020 |
Why?
|
| Central Venous Pressure | 1 | 1990 | 25 | 0.020 |
Why?
|
| Cardiac Catheterization | 1 | 1994 | 632 | 0.020 |
Why?
|
| Methods | 1 | 1990 | 149 | 0.020 |
Why?
|
| Silicone Elastomers | 1 | 1990 | 35 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 836 | 0.020 |
Why?
|
| Base Sequence | 2 | 2001 | 3089 | 0.020 |
Why?
|
| Cellulitis | 1 | 1990 | 63 | 0.020 |
Why?
|
| Peritonitis | 1 | 1990 | 75 | 0.020 |
Why?
|
| Karyotyping | 1 | 2010 | 328 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 1990 | 125 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 1997 | 1010 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2010 | 427 | 0.020 |
Why?
|
| Vaginosis, Bacterial | 1 | 2008 | 18 | 0.020 |
Why?
|
| Prostaglandins | 1 | 2009 | 48 | 0.020 |
Why?
|
| Peer Review, Health Care | 1 | 2009 | 17 | 0.020 |
Why?
|
| Pregnancy-Associated Plasma Protein-A | 1 | 2008 | 7 | 0.020 |
Why?
|
| Prostheses and Implants | 1 | 1990 | 151 | 0.020 |
Why?
|
| Terminal Care | 1 | 1990 | 111 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 1992 | 1630 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2008 | 113 | 0.020 |
Why?
|
| Elective Surgical Procedures | 1 | 2008 | 158 | 0.020 |
Why?
|
| Hospitals, Proprietary | 1 | 2007 | 2 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2521 | 0.020 |
Why?
|
| Quality Assurance, Health Care | 1 | 2009 | 206 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2008 | 267 | 0.020 |
Why?
|
| HIV Infections | 1 | 2019 | 1891 | 0.020 |
Why?
|
| Sexual Behavior | 1 | 2008 | 244 | 0.020 |
Why?
|
| Genes, Viral | 1 | 1987 | 185 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1987 | 184 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1987 | 395 | 0.020 |
Why?
|
| Introns | 1 | 1987 | 299 | 0.020 |
Why?
|
| Palliative Care | 1 | 1990 | 427 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 1990 | 418 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2008 | 198 | 0.020 |
Why?
|
| Retreatment | 1 | 2005 | 88 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2013 | 877 | 0.020 |
Why?
|
| Platelet Count | 2 | 1997 | 136 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2016 | 4503 | 0.010 |
Why?
|
| Erythrocyte Count | 2 | 1994 | 21 | 0.010 |
Why?
|
| Reticulocytes | 2 | 1994 | 42 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1987 | 1079 | 0.010 |
Why?
|
| Nitrogen Isotopes | 1 | 2003 | 63 | 0.010 |
Why?
|
| Recurrence | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Hemoglobins | 2 | 1994 | 303 | 0.010 |
Why?
|
| Abortion, Habitual | 1 | 2001 | 16 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2001 | 41 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2001 | 79 | 0.010 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2001 | 59 | 0.010 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2001 | 26 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 1323 | 0.010 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2001 | 49 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2001 | 77 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 227 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2001 | 120 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2001 | 155 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 292 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2001 | 830 | 0.010 |
Why?
|
| Estrone | 1 | 1999 | 9 | 0.010 |
Why?
|
| Polyunsaturated Alkamides | 1 | 1999 | 28 | 0.010 |
Why?
|
| Quintuplets | 1 | 1998 | 1 | 0.010 |
Why?
|
| Quadruplets | 1 | 1998 | 2 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 256 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 1997 | 2084 | 0.010 |
Why?
|
| Elastic Tissue | 1 | 1997 | 19 | 0.010 |
Why?
|
| Vacuoles | 1 | 1997 | 24 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2001 | 669 | 0.010 |
Why?
|
| Erythropoietin | 1 | 1998 | 104 | 0.010 |
Why?
|
| Aged | 1 | 1995 | 19545 | 0.010 |
Why?
|
| Hematuria | 1 | 1997 | 55 | 0.010 |
Why?
|
| Postoperative Care | 1 | 1998 | 295 | 0.010 |
Why?
|
| Pregnancy, High-Risk | 1 | 1995 | 43 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 1999 | 797 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1997 | 676 | 0.010 |
Why?
|
| Ritodrine | 1 | 1994 | 1 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 132 | 0.010 |
Why?
|
| Terbutaline | 1 | 1994 | 6 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 1390 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 219 | 0.010 |
Why?
|
| Plasma Exchange | 1 | 1995 | 84 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 1994 | 250 | 0.010 |
Why?
|
| Testosterone | 1 | 1999 | 535 | 0.010 |
Why?
|
| Random Allocation | 1 | 1994 | 436 | 0.010 |
Why?
|
| Exchange Transfusion, Whole Blood | 1 | 1993 | 14 | 0.010 |
Why?
|
| Stroke Volume | 1 | 1995 | 487 | 0.010 |
Why?
|